Scolioscan Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.38M

  • Investors
  • 5

Scolioscan General Information

Description

Manufacturer of a radiation-free 3D ultrasound scoliosis assessment system designed for safe spinal monitoring. The company offers three-dimensional ultrasound imaging, spatial sensing, positioning systems, artificial intelligence integration, automated spinal curvature measurement, and cloud-based data management, enabling healthcare professionals to perform frequent spinal assessments without radiation exposure.

Contact Information

Formerly Known As
WISDOM ABLE
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Flat 301-302, 3/Floor, Building 3E
  • Hong Kong Science Park, Pak Shek Kok, New Territories
  • Hong Kong
  • Hong Kong
+852 2602
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Flat 301-302, 3/Floor, Building 3E
  • Hong Kong Science Park, Pak Shek Kok, New Territories
  • Hong Kong
  • Hong Kong
+852 2602

Scolioscan Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scolioscan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 26-Apr-2024 $6.38M Completed Generating Revenue
3. Later Stage VC 26-Apr-2024 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Jan-2023 $155K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2021 $155K $155K Completed Generating Revenue
To view Scolioscan’s complete valuation and funding history, request access »

Scolioscan Patents

Scolioscan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022265022-A1 Three-dimensional ultrasonic imaging method and system based on laser radar Inactive 28-Apr-2021
EP-4332632-A1 Three-dimensional ultrasonic imaging method and system based on laser radar Inactive 28-Apr-2021
EP-4332632-A4 Three-dimensional ultrasonic imaging method and system based on laser radar Inactive 28-Apr-2021
WO-2022228461-A1 Three-dimensional ultrasonic imaging method and system based on laser radar Inactive 28-Apr-2021
CA-3217106-A1 Three-dimensional ultrasonic imaging method and system based on lidar Pending 28-Apr-2021 G01S15/89
To view Scolioscan’s complete patent history, request access »

Scolioscan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scolioscan Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alibaba Entrepreneurs Fund Corporate Venture Capital Minority
Fosun Pharma Corporation Minority
Gobi Partners Venture Capital Minority
The Hong Kong Polytechnic University University Minority
Hong Kong Science & Technology Parks Accelerator/Incubator Minority
To view Scolioscan’s complete investors history, request access »

Scolioscan FAQs

  • When was Scolioscan founded?

    Scolioscan was founded in 2012.

  • Where is Scolioscan headquartered?

    Scolioscan is headquartered in Hong Kong, Hong Kong.

  • What is the size of Scolioscan?

    Scolioscan has 8 total employees.

  • What industry is Scolioscan in?

    Scolioscan’s primary industry is Diagnostic Equipment.

  • Is Scolioscan a private or public company?

    Scolioscan is a Private company.

  • What is Scolioscan’s current revenue?

    The current revenue for Scolioscan is .

  • How much funding has Scolioscan raised over time?

    Scolioscan has raised $14.2M.

  • Who are Scolioscan’s investors?

    Alibaba Entrepreneurs Fund, Fosun Pharma, Gobi Partners, The Hong Kong Polytechnic University, and Hong Kong Science & Technology Parks have invested in Scolioscan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process